International Stem Cell Corporation , a California-based biotechnology company developing novel stem cell-based therapies and biomedical products announced today that Dr. Ruslan Semechkin, ISCO's Chief Scientific Officer, will present data from its pre-clinical primate studies of Parkinson's disease at the 66th American Academy of Neurology Annual ... (more)
http://ift.tt/1rmlMsF
http://ift.tt/1rmlMsF
No comments:
Post a Comment